AVGO Stock Slides After Q4 Beat on Margin Concerns Skip to Main Content

Broadcom Stock Falls Despite Q4 Beat as Margin Risks Rise

|
Share on social media

Broadcom Inc. (AVGO) stock reported strong Q4 fiscal 2025 results after market close on December 11, beating expectations with adjusted EPS of $1.95 (versus $1.86 estimated) and revenue of $18.0 billion (up 28% year-over-year). Despite the beat and raised Q1 guidance of $19.1 billion versus $18.3 billion estimated, shares plunged the following day as management warnings about Q1 margin squeeze and 2026 tax hikes overshadowed record AI revenue growth.

avgo stock logo

Key Drivers of the AVGO Stock Move

  • Main Catalyst: Management guided for near-term margin compression and highlighted 2026 tax headwinds, triggering profit-taking despite the AI revenue momentum. Analyst concerns over the cautious outlook dragged semiconductor peers lower across the board.
  • Bull Case: Broadcom locked in Samsung’s HBM supply for Google AI chips, with custom AI chip revenue expected to reach $50 billion in 2026. Strong hyperscaler relationships (discussions with Microsoft on custom AI designs) and a 10.2% dividend increase from $0.59 to $0.65 demonstrate confidence in long-term cash generation. Seven consecutive quarters of record revenue support the structural AI thesis.
  • Bear Case: Shrinking gross margins and elevated valuation (PE ratio of ~85) leave limited room for error. The semiconductor sector faces growing concerns about an AI bubble, amplified by rising Treasury yields pressuring growth stocks. Custom chip competition from Marvell and internal hyperscaler efforts pose long-term market share risks.
AVGO stock graph

The stock trades at a $1.92 trillion market cap following the selloff. While analyst price target raises (median now near $450) reflect optimism about AI infrastructure demand, near-term execution risks around margins and the uncertain macro backdrop create volatility. Investors face the classic dilemma: robust demand fundamentals against valuation strain and profit-taking after a 74% year-to-date gain through December 10.

AVGO Smart Money Activity

Director Henry Samueli executed a significant $128.3 million stock sale on December 8, disposing of 320,316 shares. Another director, Justine Page, sold $264,900 worth of shares on November 14. On the congressional side, activity was mixed: Representative Jared Moskowitz (D) made three purchases in October totaling up to $80,000 with gains near 20%, while Representative Michael McCaul (R) sold $50,000 to $100,000 worth in late October. The heavy insider selling by directors, particularly Samueli’s nine-figure disposal, could signal caution despite the company’s AI tailwinds.

AVGO smart money table

AVGO Unusual Options

Options flow on December 11 revealed intense activity ahead of earnings, with over $6.6 million in premiums paid on a single January 2026 $275 call trade. Heavy put buying emerged post-earnings, including $344,500 in January 2026 $380 puts and $239,000 in March 2026 $370 puts, signaling hedging or bearish positioning. December 12 activity showed defensive flows continuing with $128,600 in near-term $375 puts. The mix of bullish long-dated calls and near-term protective puts reflects uncertainty about whether the margin concerns represent a buying opportunity or a fundamental shift in the growth trajectory.

AVGO unusual options flow chart

AVGO Seasonality

Based on monthly data since December 2020 (average 5 samples per month), AVGO historically performs strongest in December (83% positive periods, average gain of 14.6%), May (100% positive, 13.0% average gain), and November (80% positive, 7.2% gain). The current December selloff contradicts the seasonally favorable pattern. Weaker months include April (20% positive, -0.6% average) and January (60% positive, -0.7% average), suggesting potential continued pressure into early 2026 if historical patterns hold.

AVGO seasonality chart

AVGO Relative Performance

Broadcom’s quarterly relative performance versus the technology sector deteriorated sharply in early December, falling from the 87th percentile on November 28 to the 73rd percentile by December 11. The post-earnings collapse further compressed relative strength, underperforming nearly three-quarters of sector peers. This marks a reversal from the strong outperformance seen through mid-November when the stock briefly touched the 86th percentile. The rotation out of expensive semiconductors into industrials and financials has particularly pressured AVGO given its premium valuation.

AVGO Analyst Focus

Wall Street remains overwhelmingly bullish despite the margin concerns, with seven firms raising price targets between November 26 and December 12. UBS leads with a $472 target (up from $415), followed by Bank of America at $460, Susquehanna at $450, and Morgan Stanley at $443. The median analyst target sits near $450, implying 20% upside from current levels. KeyBanc and Bank of America both raised their targets to $500 on December 12, maintaining overweight/buy ratings. No downgrades or sell ratings emerged during the period, suggesting analysts view the selloff as a margin reset rather than a breakdown in the AI demand story. All seven rating actions were confirmations with raised targets, reinforcing the structural bull case on AI infrastructure spending.

AVGO analyst table

Stay up-to-date: Subscribe to posts like this!

Receive automated updates from the Posts category
This site is protected by reCAPTCHA and the Google Privacy Policy and Google Terms of Service apply. Don't worry, we hate spam, too! See TrendSpider Privacy Policy for details.

Latest posts

|

Jensen Huang Resigns as NVIDIA CEO: What it Means for NVDA Stock

After 33 years at the helm of the company he co-founded, Jensen Huang resigned as President, CEO, and board member of NVDA effective immediately on November 12, 2026. The departure was triggered by a deepening scandal involving alleged ties to a suspected Chinese intelligence asset, a second workplace affair, and a cascade of regulatory and […]
|

CoreWeave Stock Q3 Earnings: $3.7B Revenue Beat & 2026 Guide Raise

CoreWeave (CRWV) stock delivered a commanding Q3 2026 earnings beat on November 10, posting revenue of $3.7 billion against a consensus estimate of $3.5 billion and an adjusted EPS loss of $0.95 versus the expected $1.53 — a 38% EPS beat. The company simultaneously raised its full-year 2026 revenue guidance to $13.0–$13.3 billion, sparking an […]
|

Hims & Hers Stock Slides as Q3 EPS Miss & Weak Guide Shadow 49% Sales

Hims & Hers Health (HIMS) stock delivered another quarter of robust top-line expansion in Q3 2026, with revenue surging 48.7% year-over-year to $890.4M. However, an adjusted EPS miss and a materially below-consensus Q4 outlook sent shares sharply lower after the report, reflecting growing investor concern about profitability and the post-GLP-1 compounding transition. Key Takeaways: Beat […]
|

Rocket Lab Corporation Stock Drops as Q3 EPS Miss & Neutron Slip Outshine 73% Sales

Rocket Lab Corporation (RKLB) stock reported its strongest quarter on record in Q3 2026, with revenue surging 72.7% year-over-year to $267.8M, beating the $257.0M consensus by 4.2%. However, an adjusted EPS miss of -$0.08 versus the -$0.07 estimate, compounding concerns around the Neutron rocket’s delayed debut, sent shares tumbling more than 8% in after-hours trading […]